Transarterial Chemoembolization related to Good Survival for Selected Patients with advanced Hepatocellular Carcinoma
Conclusion: We found four risk factors were associated with dismal overall survival for advanced HCC patients: serum GGT level, serum CRP, serum ALP and presence of PVTT. TACE may be recommended for patients with advanced HCC with 0-1 risk factors due to the favourable prognosis.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Yong Le, Jing-Xian Shen, Yong-Fa Zhang, Min-Ke He, Anna Kan, Hai-Long Chen, Zi-Shan Yu, Qi-Jiong Li, Ming Shi Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Study | Thrombosis | Urology & Nephrology